TY - JOUR
T1 - Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers
AU - Pérez-Guijarro, Eva
AU - Karras, Panagiotis
AU - Cifdaloz, Metehan
AU - Martínez-Herranz, Raúl
AU - Canõn, Estela
AU - Granã, Osvaldo
AU - Horcajada-Reales, Celia
AU - Alonso-Curbelo, Direna
AU - Calvo, Tonantzin G.
AU - Gómez-López, Gonzalo
AU - Bellora, Nicolas
AU - Riveiro-Falkenbach, Erica
AU - Ortiz-Romero, Pablo L.
AU - Rodríguez-Peralto, José L.
AU - Maestre, Lorena
AU - Roncador, Giovanna
AU - De Agustín Asensio, Juan C.
AU - Goding, Colin R.
AU - Eyras, Eduardo
AU - Megiás, Diego
AU - Méndez, Raúl
AU - Soengas, Maria S.
N1 - Publisher Copyright:
© 2016 The Author(s).
PY - 2016/11/18
Y1 - 2016/11/18
N2 - Nuclear 3'-end-polyadenylation is essential for the transport, stability and translation of virtually all eukaryotic mRNAs. Poly(A) tail extension can also occur in the cytoplasm, but the transcripts involved are incompletely understood, particularly in cancer. Here we identify a lineage-specific requirement of the cytoplasmic polyadenylation binding protein 4 (CPEB4) in malignant melanoma. CPEB4 is upregulated early in melanoma progression, as defined by computational and histological analyses. Melanoma cells are distinct from other tumour cell types in their dependency on CPEB4, not only to prevent mitotic aberrations, but to progress through G1/S cell cycle checkpoints. RNA immunoprecipitation, sequencing of bound transcripts and poly(A) length tests link the melanoma-specific functions of CPEB4 to signalling hubs specifically enriched in this disease. Essential in these CPEB4-controlled networks are the melanoma drivers MITF and RAB7A, a feature validated in clinical biopsies. These results provide new mechanistic links between cytoplasmic polyadenylation and lineage specification in melanoma.
AB - Nuclear 3'-end-polyadenylation is essential for the transport, stability and translation of virtually all eukaryotic mRNAs. Poly(A) tail extension can also occur in the cytoplasm, but the transcripts involved are incompletely understood, particularly in cancer. Here we identify a lineage-specific requirement of the cytoplasmic polyadenylation binding protein 4 (CPEB4) in malignant melanoma. CPEB4 is upregulated early in melanoma progression, as defined by computational and histological analyses. Melanoma cells are distinct from other tumour cell types in their dependency on CPEB4, not only to prevent mitotic aberrations, but to progress through G1/S cell cycle checkpoints. RNA immunoprecipitation, sequencing of bound transcripts and poly(A) length tests link the melanoma-specific functions of CPEB4 to signalling hubs specifically enriched in this disease. Essential in these CPEB4-controlled networks are the melanoma drivers MITF and RAB7A, a feature validated in clinical biopsies. These results provide new mechanistic links between cytoplasmic polyadenylation and lineage specification in melanoma.
UR - http://www.scopus.com/inward/record.url?scp=84996587351&partnerID=8YFLogxK
U2 - 10.1038/ncomms13418
DO - 10.1038/ncomms13418
M3 - Article
SN - 2041-1723
VL - 7
JO - Nature Communications
JF - Nature Communications
M1 - 13418
ER -